CYP 24 A 1 Binding to FUS Maintains Tumor Properties by Regulating the mi R ‐200c/ ZEB 1/ EMT Axis
Cancer Science · 2025
DOI: 10.1111/cas.16445 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Science, 2025. Verfasst von Ping Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Occupational and Environmental Health, School of Public Health, Suzhou Medical College of Soochow University, Suzhou, China. Hauptthemen laut MEDLINE: MicroRNAs, Vitamin D3 24-Hydroxylase, Zinc Finger E-box-Binding Homeobox 1, Ovarian Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
The active vitamin D‐degrading enzyme (CYP24A1) is commonly overexpressed in various types of cancer, which is associated with poor prognosis in cancer patients. Recent studies highlight the antagonism of CYP24A1 toward the anticancer role of active vitamin D. However, the impact of CYP24A1 on tumorigenesis and its underlying mechanisms largely remains unexplored. This study also found that high CYP24A1 mRNA expressions were associated with poor prognosis in ovarian cancer and lung adenocarcinoma (LUAD) patients. Moreover, we demonstrated that the overexpression of CYP24A1 accelerated the proliferation, migration, and invasion of ovarian cancer and LUAD cancer cells in vitro. Furthermore, knockdown of CYP24A1 displayed an anticancer effector both in vitro and in vivo. Mechanically, 87–297 amino acid motif of CYP24A1 bound specifically to FUS protein, consequentially reducing FUS affinity for miR‐200c. Considering FUS promotes gene silencing by binding to microRNA targets, a decrease in miR‐200c levels led to a notable activation of its target ZEB1, resulting in the promotion of the epithelial‐mesenchymal transition (EMT) process. In conclusion, FUS binding specifically by CYP24A1 impaired miR‐200c‐mediated ZEB1 silencing, thereby augmenting EMT progression and tumorigenesis. These findings elucidate a fundamental mechanism by which CYP24A1 operates as an oncogene, offering potential targets for therapeutic interventions in cancer treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Occupational and Environmental Health, School of Public Health, Suzhou Medical College of Soochow University, Suzhou, China.
- Department of Nutrition and Food Hygiene, School of Public Health, Suzhou Medical College of Soochow University, Suzhou, China.
- Department of Infectious Disease Surveillance and Early Warning, Qingdao Municipal Health Commission, Qingdao, China.
- Yantai Hi-Tech Industrial Development Zone Center for Disease Control and Prevention, Yantai, China.
- Department of Clinical Laboratory Center, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
- State Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and Protection, Soochow University, Suzhou, China.
ORCID-Profile: Bingyan Li
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Wang, P., Xu, J., You, W., Li, J., Yu, J., Jiang, F., Zhang, Z., Hu, W., & Li, B. (2025). CYP 24 A 1 Binding to FUS Maintains Tumor Properties by Regulating the mi R ‐200c/ ZEB 1/ EMT Axis. Cancer Science. https://doi.org/10.1111/cas.16445
Vancouver
Wang P, Xu J, You W, Li J, Yu J, Jiang F, et al. CYP 24 A 1 Binding to FUS Maintains Tumor Properties by Regulating the mi R ‐200c/ ZEB 1/ EMT Axis. Cancer Science. 2025. doi:10.1111/cas.16445
BibTeX
@article{Wang2025,
author = {Wang, Ping and Xu, Jiming and You, Weijing and Li, Jie and Yu, Jing and Jiang, Fei and Zhang, Zengli and Hu, Wentao and Li, Bingyan},
title = {CYP 24 A 1 Binding to FUS Maintains Tumor Properties by Regulating the mi R ‐200c/ ZEB 1/ EMT Axis},
journal = {Cancer Science},
year = {2025},
doi = {10.1111/cas.16445}
}
EUVIMED